Impact of bone mesenchymal stem cell (BMSC) transfusion on chronic smoking‐induced
lung inflammation is poorly understood. In this study, a rat model of smoking‐related lung …

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and irreversible lung disease of
unknown cause. It has been reported that both lung resident mesenchymal stem cells (LR …

Mesenchymal stem or stromal cells (MSC) are under investigation as a potential
immunotherapy. MSC are usually administered via intravenous infusion, after which they are …

Mesenchymal stromal cells (MSCs) reside in many organs including lung, as shown by their
isolation from fetal lung tissues, bronchial stromal compartment, bronchial-alveolar lavage …

Background: Systemic sclerosis (SSc) is a severe autoimmune disease for which
mesenchymal stromal cells (MSCs)-based therapy was reported to reduce SSc-related …

Chronic obstructive pulmonary disease (COPD) is an inflammatory airways disease with
limited therapeutic options. We have previously shown that mesenchymal stromal cell (MSC) …

Immunostimulation is recognized as an important contribution in lung fibrosis in some
animal models and patient subsets. With this review, we illustrate an additional scenario …

Mesenchymal stromal/stem cells (MSCs) have a great potential to proliferate, undergo multi‐
directional differentiation, and exert immunoregulatory effects. There is already much …

Idiopathic pulmonary fibrosis (IPF) is a fibroproliferative disease with irreversible lung
function loss and poor survival. Myeloid-derived suppressor cells (MDSC) are associated …

Background Pulmonary fibrosis (PF) is a growing clinical problem with limited therapeutic
options. Human umbilical cord mesenchymal stromal cell (hucMSC) therapy is being …